Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?
AUTOR(ES)
Neugebauer, Maria Gertrudes Fernandes Pereira, Neugebauer, Samuel Antônio, Almeida Junior, Hiram Larangeira, Mota, Laís Marques
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2015-02
RESUMO
Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum.
Documentos Relacionados
- Transcutaneous electrical nerve stimulation in osteoarthrosis: a therapeutic alternative?
- Differential Identification of Mycobacterium kansasii and Mycobacterium marinum
- Antibiotic Susceptibility Pattern of Mycobacterium marinum
- Identification of Two Mycobacterium marinum Loci That Affect Interactions with Macrophages
- Relation of Infection to Tissue Temperature in Mice Infected with Mycobacterium marinum and Mycobacterium leprae
